MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.

* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 

Deferasirox treatment for myelodysplastic syndromes: real-life efficacy and safety in a single-institution patient population

Breccia M et al. – The oral iron chelator deferasirox is effective and safe when used in myelodysplastic syndromes (MDS) patients with transfusion requirement, also if administered concomitantly with other drugs. [more...]


Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here